
Acme United Corporation Income Statement 2025-2009 | ACU
Brief overview of financial results at Acme United Corporation
The conclusions below are based on five years of reported results. According to figures from Acme United Corporation, revenue changed from $164 million to $197 million over five years. Across the full period, sales moved by +19.8%; the average annual rate was 3.7%. The scale of the core business was largely unchanged.
The gross result shifted from $59.6 million to $77.4 million, or +29.9%. The cost base moved more slowly than the top line, which supported margins. Comparing the endpoints gives gross margins of 36.3% and 39.4%. The business retained more gross profit from each unit of revenue.
Over the period, EBITDA shifted from $13.8 million to $21.1 million, a change of +52.2%. Additional revenue translated efficiently into EBITDA. The EBITDA share of revenue changed from 8.4% to 10.7%. A wider margin confirms stronger operating efficiency.
The net result moved from 8.1 million dollars to 10.2 million dollars, or +25.8%. Net earnings remained broadly steady over the period.
The market value of the business moved from 105 million dollars to 163 million dollars, or +55.8%. Higher capitalization indicates improving investor confidence.
Financial takeaway
The results present an uneven picture without one dominant signal. The positive side is supported by an improving EBITDA margin, a stronger final result and a stronger gross margin. Caution is warranted because of a softer top-line trend. The key question is whether sales can be converted into sustainable profit.
Annual Income Statement Acme United Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
163 M | 137 M | 142 M | 88.4 M | 114 M | 105 M | 81.4 M | 57.4 M | 80 M | 80.8 M | 46.2 M | 61.2 M | 46 M | 37.8 M | 30.6 M | - | - |
Shares |
3.79 M | 3.7 M | 3.57 M | 3.53 M | 3.47 M | 3.35 M | 3.35 M | 3.37 M | 3.36 M | 3.33 M | 3.34 M | 3.24 M | 3.17 M | 3.12 M | 3.1 M | - | - |
Historical Prices |
43.2 | 37 | 39.7 | 25.1 | 32.7 | 34.3 | 22.2 | 16 | 21.5 | 23.2 | 13.4 | 16.6 | 13.4 | 10.3 | 8.02 | 11.3 | 8.05 |
Net Income |
10.2 M | 10 M | 17.8 M | 3.03 M | 13.7 M | 8.1 M | 5.51 M | 4.6 M | 4.05 M | 5.85 M | 4.79 M | 4.79 M | 4 M | 3.55 M | 2.81 M | 2.57 M | - |
Revenue |
197 M | 194 M | 192 M | 194 M | 182 M | 164 M | 142 M | 137 M | 131 M | 125 M | 110 M | 107 M | 89.6 M | 84.4 M | 73.3 M | - | - |
Cost of Revenue |
119 M | 118 M | 119 M | 130 M | 117 M | 104 M | 90.5 M | 86.7 M | 82.7 M | - | - | - | - | - | - | - | - |
Gross Profit |
77.4 M | 76.4 M | 72.2 M | 63.6 M | 64.8 M | 59.6 M | 52 M | 50.6 M | 47.9 M | 45.6 M | 39.6 M | 38.2 M | 31.8 M | 29.7 M | 26.3 M | 23.4 M | - |
Operating Income |
14.7 M | 14.1 M | 13.2 M | 6.27 M | 12.8 M | 11.4 M | 8.43 M | 7.46 M | 7.88 M | 8.44 M | 7.35 M | 7.39 M | 5.88 M | 5.36 M | 4.28 M | 2.98 M | - |
Interest Expense |
-47 K | 95.1 K | -41 K | -246 K | -195 K | -666 K | -97.7 K | -67.5 K | -62.6 K | -76.8 K | -167 K | -118 K | -34.9 K | -99.1 K | -4.38 K | 72.4 K | - |
EBITDA |
21.1 M | 20.2 M | 18.2 M | 10.9 M | 16.8 M | 13.8 M | 11.9 M | 10.7 M | 10.7 M | 10.9 M | 9.4 M | 9.09 M | 7.08 M | 6.45 M | 5.26 M | 3.74 M | - |
Operating Expenses |
- | - | - | - | - | 48.2 M | 43.6 M | 43.2 M | 40.1 M | 37.1 M | 32.2 M | 30.8 M | 25.9 M | 24.4 M | 22 M | - | - |
General and Administrative Expenses |
62.7 M | 62.2 M | 59 M | 57.3 M | 52 M | 48.2 M | 43.6 M | 43.2 M | 40.1 M | 37.1 M | 32.2 M | 30.8 M | 25.9 M | 24.4 M | 22 M | 20.4 M | - |
All numbers in USD currency
Quarterly Income Statement Acme United Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
3.81 M | 3.8 M | 3.78 M | 3.75 M | 3.75 M | 3.73 M | 3.68 M | 3.65 M | 3.65 M | 3.58 M | 3.56 M | 3.54 M | 3.54 M | 3.53 M | 3.52 M | 3.52 M | 3.52 M | 3.54 M | 3.35 M | 3.35 M | 3.34 M | 3.34 M | 3.35 M | 3.35 M | - | 3.35 M | 3.35 M | 3.35 M | 4.84 M | 3.37 M | 3.37 M | 3.37 M | 4.84 M | 3.37 M | 3.35 M | 3.33 M | - | 3.32 M | 3.32 M | 3.34 M | - | 3.35 M | 3.3 M | 3.3 M | - | 3.25 M | 3.21 M | 3.2 M | - | 3.19 M | 3.16 M | 3.13 M | - | 3.1 M | 3.1 M | 3.13 M | - | 3.1 M | 3.1 M | 3.08 M |
Net Income |
985 K | 1.9 M | 4.75 M | 1.65 M | - | 2.23 M | 4.45 M | 1.64 M | - | 2.15 M | 3.44 M | 990 K | - | 64 K | 2.74 M | 830 K | - | 2.05 M | 7.23 M | 2.05 M | - | 1.58 M | 3.2 M | 1.28 M | 978 K | 1.06 M | 2.67 M | 807 K | 591 K | 807 K | 2.44 M | 764 K | -655 K | 1.2 M | 2.85 M | 659 K | 545 K | 1.47 M | 3.27 M | 565 K | 440 K | 1.21 M | 2.71 M | 436 K | 689 K | 1.19 M | 2.54 M | 368 K | 524 K | 959 K | 2.21 M | 309 K | 430 K | 798 K | 2.06 M | 260 K | 266 K | 682 K | 1.74 M | 120 K |
Revenue |
52.3 M | 49.1 M | 54 M | 46 M | - | 48.2 M | 55.4 M | 45 M | - | 50.4 M | 53.3 M | 45.8 M | - | 49.7 M | 56.8 M | 43.3 M | - | 47.9 M | 44.8 M | 43.5 M | - | 43.3 M | 44 M | 35.8 M | 33.9 M | 37 M | 40.2 M | 31.4 M | 31.1 M | 34.7 M | 39.8 M | 31.7 M | 30.2 M | 33.8 M | 38.8 M | 27.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
31.5 M | 29.9 M | 31.8 M | 28 M | - | 29.6 M | 32.8 M | 27.6 M | - | 30.9 M | 33.3 M | 29.6 M | - | 33.8 M | 38.2 M | 28.4 M | - | 30.9 M | 28.7 M | 27.9 M | - | 28.4 M | 28 M | 22.2 M | 21.6 M | 23.9 M | 25.4 M | 19.6 M | 19.8 M | 22.3 M | 25 M | 19.6 M | 19.5 M | 21.6 M | 24.4 M | 17.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
20.8 M | 19.2 M | 22.1 M | 17.9 M | - | 18.6 M | 22.6 M | 17.4 M | - | 19.5 M | 20 M | 16.3 M | - | 15.9 M | 18.5 M | 15 M | - | 17 M | 16.2 M | 15.6 M | - | 15 M | 16.1 M | 13.5 M | 12.3 M | 13.1 M | 14.8 M | 11.8 M | 11.4 M | 12.4 M | 14.7 M | 12.1 M | 10.6 M | 12.2 M | 14.5 M | 10.6 M | 9.81 M | 11.9 M | 14.7 M | 9.18 M | - | 10.3 M | 12.5 M | 8.44 M | - | 10.6 M | 11.7 M | 6.88 M | - | 7.94 M | 10.1 M | 6.43 M | - | 7.43 M | 9.82 M | 5.94 M | - | 6.64 M | 8.68 M | 5.31 M |
Operating Income |
1.75 M | 3.01 M | 6.39 M | 2.43 M | - | 2.93 M | 6.38 M | 2.56 M | - | 3.66 M | 5.25 M | 2.19 M | - | 953 K | 3.98 M | 1.37 M | - | 2.96 M | 3.79 M | 2.97 M | - | 2.12 M | 4.38 M | 2.01 M | - | 1.73 M | 3.77 M | 1.53 M | - | 1.37 M | 3.62 M | 1.36 M | - | 1.97 M | 3.91 M | 1.21 M | - | 2.14 M | 4.64 M | 955 K | - | 1.99 M | 3.88 M | 827 K | - | 1.93 M | 3.74 M | 625 K | - | 1.41 M | 3.19 M | 513 K | - | 1.36 M | 3.08 M | 458 K | - | 1.12 M | 2.46 M | 183 K |
Interest Expense |
-16 K | -146 K | 99 K | 90 K | - | 17 K | 28 K | 44 K | - | -55 K | 23 K | 23 K | - | -209 K | -148 K | 2 K | - | -68 K | -68 K | -77 K | - | 35 K | 1 K | -43 K | - | -40 K | -14 K | 2 K | - | -23 K | -74 K | 13 K | - | -37 K | 29 K | -13 K | - | -65 K | -11 K | 38 K | - | -92 K | 20 K | -76 K | - | -67 K | 3 K | -19 K | - | 13 K | -25 K | -3 K | - | -7 K | -43 K | -42 K | - | -20 K | -3 K | 25 K |
EBITDA |
3.72 M | 4.61 M | 7.91 M | 3.93 M | - | 4.45 M | 7.85 M | 4.02 M | - | - | - | 2.91 M | - | 2.96 M | 5.32 M | 2.02 M | - | 4.77 M | 4.96 M | 3.55 M | - | 3.95 M | 5.51 M | 2.58 M | - | 3.37 M | 4.87 M | 2.08 M | - | 2.85 M | 4.57 M | 1.84 M | - | 3.22 M | 4.72 M | 1.61 M | - | 3.24 M | 5.36 M | 1.31 M | - | 2.96 M | 4.52 M | 1.15 M | - | 2.83 M | 4.28 M | 881 K | - | 2.08 M | 3.65 M | 733 K | - | 1.98 M | 3.5 M | 667 K | - | 1.72 M | 2.86 M | 380 K |
General and Administrative Expenses |
19 M | 16.2 M | 15.8 M | 15.5 M | - | 15.6 M | 16.3 M | 14.8 M | - | 15.8 M | 14.8 M | 14.1 M | - | 15 M | 14.6 M | 13.6 M | - | 14 M | 12.4 M | 12.6 M | - | 12.8 M | 11.7 M | 11.5 M | - | 11.4 M | 11 M | 10.3 M | - | 11.1 M | 11.1 M | 10.8 M | - | 10.3 M | 10.6 M | 9.35 M | - | 9.72 M | 10.1 M | 8.23 M | - | 8.33 M | 8.66 M | 7.61 M | - | 8.68 M | 7.98 M | 6.25 M | - | 6.53 M | 6.89 M | 5.91 M | - | 6.07 M | 6.74 M | 5.49 M | - | 5.52 M | 6.22 M | 5.12 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Acme United Corporation (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Household products industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - | |
|
United-Guardian
UG
|
$ 7.76 | -2.39 % | $ 35.7 M | ||
|
Dogness (International) Corporation
DOGZ
|
$ 0.95 | -5.94 % | $ 12.7 M | ||
|
Revlon
REV
|
- | -4.41 % | $ 212 M | ||
|
e.l.f. Beauty
ELF
|
$ 76.15 | -3.64 % | $ 4.17 B | ||
|
Coty
COTY
|
$ 2.6 | -4.94 % | $ 2.26 B | ||
|
Spectrum Brands Holdings
SPB
|
$ 87.43 | -1.76 % | $ 2.25 B | ||
|
Hims & Hers Health
HIMS
|
$ 32.74 | 3.41 % | $ 7.37 B | ||
|
Helen of Troy Limited
HELE
|
$ 26.84 | -4.79 % | $ 617 M | ||
|
Edgewell Personal Care Company
EPC
|
$ 26.69 | -3.47 % | $ 1.27 B | ||
|
The Clorox Company
CLX
|
$ 93.8 | -2.03 % | $ 11.6 B | ||
|
Church & Dwight Co.
CHD
|
$ 96.19 | -0.97 % | $ 23.3 B | ||
|
Newell Brands
NWL
|
$ 5.03 | -6.68 % | $ 2.1 B | ||
|
Unilever PLC
UL
|
$ 60.21 | -2.62 % | $ 131 B | ||
|
Kimberly-Clark Corporation
KMB
|
$ 107.31 | -1.44 % | $ 35.6 B | ||
|
Nature's Sunshine Products
NATR
|
$ 20.52 | -1.44 % | $ 369 M | ||
|
Nu Skin Enterprises
NUS
|
$ 5.08 | -2.5 % | $ 250 M | ||
|
LifeVantage Corporation
LFVN
|
$ 6.27 | -1.26 % | $ 76.8 M | ||
|
The Estée Lauder Companies
EL
|
$ 79.92 | -3.28 % | $ 28.8 B | ||
|
USANA Health Sciences
USNA
|
$ 20.92 | -5.6 % | $ 388 M | ||
|
The Procter & Gamble Company
PG
|
$ 146.97 | -1.47 % | $ 345 B | ||
|
Mannatech, Incorporated
MTEX
|
$ 4.66 | 6.39 % | $ 8.86 M | ||
|
Colgate-Palmolive Company
CL
|
$ 90.08 | -1.69 % | $ 72.8 B | ||
|
Inter Parfums
IPAR
|
$ 119.75 | -2.02 % | $ 3.84 B |